Tomas Olsson
Researcher Next ID · RN-023471
Researcher · Medicine
Karolinska University Hospital
Stockholm, Sweden
- Works count
- 1,003
- Citation count
- 59,997
- H-index
- 119
- i10-index
- 646
Research interests
Publications
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
JAMA Neurology · 2021 · 10.1001/jamaneurol.2021.1858
Environmental and genetic risk factors for MS: an integrated review
Annals of Clinical and Translational Neurology · 2019 · 10.1002/acn3.50862
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
JAMA Neurology · 2019 · https://doi.org/10.1001/jamaneurol.2019.1534
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurology · 2019 · 10.1001/jamaneurol.2019.3365
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Cell · 2018 · 10.1016/j.cell.2018.08.011
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Multiple Sclerosis Journal · 2018 · https://doi.org/10.1177/1352458517751049
Overexpression of the Cytokine BAFF and Autoimmunity Risk
New England Journal of Medicine · 2017 · 10.1056/nejmoa1610528
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Neurology · 2017 · 10.1212/wnl.0000000000004683
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Nature Reviews Neurology · 2016 · https://doi.org/10.1038/nrneurol.2016.187
γ-secretase directly sheds the survival receptor BCMA from plasma cells
Nature Communications · 2015 · 10.1038/ncomms8333
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Neurology · 2014 · 10.1016/s1474-4422(13)70308-9
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial
Multiple Sclerosis Journal · 2013 · 10.1177/1352458513507821
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects
PLoS Genetics · 2013 · 10.1371/journal.pgen.1003926
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women
Multiple Sclerosis Journal · 2012 · 10.1177/1352458512436596
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1014656
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
Annals of Neurology · 2010 · 10.1002/ana.22247
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice
Autoimmunity Reviews · 2010 · 10.1016/j.autrev.2010.06.009
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis
Neurology · 2009 · 10.1212/wnl.0b013e3181b59c40
Neurofascin as a novel target for autoantibody-mediated axonal injury
The Journal of Experimental Medicine · 2007 · 10.1084/jem.20071053
Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis
Nature Genetics · 2007 · 10.1038/ng2106
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
Nature Genetics · 2005 · 10.1038/ng1544
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
American Journal Of Pathology · 2000 · https://doi.org/10.1016/s0002-9440(10)64537-3
Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology
Brain Pathology · 1998 · 10.1111/j.1750-3639.1998.tb00194.x
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
The Journal of Immunology · 1991 · 10.4049/jimmunol.146.5.1490
Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.
Journal of Clinical Investigation · 1990 · 10.1172/jci114800
Current projects
No projects listed.